UAE (United Arab Emirates) blood transfusion and screening procedures improve
This article was originally published in Clinica
Executive Summary
The UAE is to improve its blood transfusion services by extending the use of technology for removing leukocyte from blood by filtration. The ministry of health previously only allowed the process, known as leukodepletion, to be used in critical procedures such as dialysis and cases of patients with immune deficiencies. Dr Abdul Raheem Jaffar, under-secretary at the health ministry, told the Khaleej Times that the government's decision to extend leukodepletion, for which it spends Dh20 million ($5.4 million) a year was aimed at guaranteeing the safety of patients. He added that due to the strict criteria of donor selection, blood transfusion in the UAE was now 100% safe.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.